Clinical Trials Logo

Ménière clinical trials

View clinical trials related to Ménière.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT04677972 Active, not recruiting - Meniere Disease Clinical Trials

SPI-1005 for the Treatment of Meniere's Disease

STOPMD-3
Start date: August 2, 2022
Phase: Phase 3
Study type: Interventional

The study is a randomized, double-blind, placebo-controlled, multi-center clinical trial (RCT) with open-label extension study (OLE), of SPI-1005 in adult subjects with definite Meniere's disease with active symptoms within three months preceding study enrollment.